news

• 2025-03-03

  Breakthrough! Exciting interim Phase II Data of LP-003 in CSU released by Longbio at AAAAI 2025

  more
• 2024-11-25

  Food Allergy: LongBio's LP-003 achieves its fourth IND approval

  more
• 2024-09-24

  LongBio announced the completion of Series B2 financing, led by Qiming Venture Partners

  more
• 2024-04-16

  Pre-clinical result of LP-005, a novel bi-functional complement antibody-fusion protein was unveiled by LongBio at WCN2024

  more
• 2024-03-12

  Longbio Pharma Presented Positive Phase 1 Results for LP-003 at 2024AAD

  more